VKTX Next Earnings Date Notes

— Viking Therapeutics (VKTX) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for metabolic & endocrine disorders, including non-alcoholic steatohepatitis (NASH), obesity, & other metabolic diseases. Their lead candidates, such as VK2809 (for NASH & lipid disorders) & VK2735 (for obesity), target key metabolic pathways with the potential for significant clinical impact. As an investor preparing for the next earnings call, it's crucial to look beyond current revenues, which remain negligible as Viking has not yet commercialized a therapy. Instead, focus on pipeline progress: any updates on clinical trial results (especially for VK2809 & VK2735), enrollment status, and anticipated regulatory milestones. Pay attention to R&D expenditure trends and cash runway, as these indicate Viking's capacity to fund ongoing trials through key catalysts. Partnerships or licensing agreements with larger pharmaceutical companies can also signal validation & potential near-term value. In sum, for Viking, clinical milestones—particularly successful late-stage data and FDA interactions—are the most critical metrics for assessing long-term potential and future value creation. The next projected earnings date for VKTX is 7/22/2026 after close (stay tuned for a confirmed earnings date once announced).

VKTX Next Earnings Date FAQ

On this page we presented the VKTX Next Earnings Date information for Viking Therapeutics along with recent past earnings dates. For Q1 of 2026, VKTX reported earnings of -1.370/share, with the earnings report taking place on 4/29/2026. For Q4 of 2025, VKTX reported earnings of -1.380/share, with the earnings report taking place on 2/11/2026. For Q3 of 2025, VKTX reported earnings of -0.810/share, with the earnings report taking place on 10/22/2025. For Q2 of 2025, VKTX reported earnings of -0.580/share, with the earnings report taking place on 7/23/2025. For Q1 of 2025, VKTX reported earnings of -0.410/share, with the earnings report taking place on 4/23/2025. Based on these past earnings dates, the projected next earnings date for VKTX is 7/22/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Viking Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Viking Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Viking Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next VKTX earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up VKTX's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the VKTX next earnings date.